Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | n/a | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | n/a | n/a |
Pr/Book | n/a |
Latest | F'cast | |
---|---|---|
Revenue | n/a | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | n/a | (2.33) | (0.33)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | n/a | (2.67) | 0.00¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | n/a | (1.79) | (0.13)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | n/a | (2.61) | (0.19)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | n/a | (2.39) | (0.17)¢ | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Director Dealing | 07-Apr-2025 | 11:46 | RNS |
Clinical Trial Update | 31-Mar-2025 | 07:00 | RNS |
Innovate UK Grant Award | 27-Mar-2025 | 07:00 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 19.50p |
Change Today | -0.50p |
% Change | -2.50 % |
52 Week High | 20.00 |
52 Week Low | 18.00 |
Volume | 75,724 |
Shares Issued | 32.68m |
Market Cap | £6.37m |
Value | ![]() |
---|
Value | ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
Latest | Previous | |
---|---|---|
Special | Interim | |
Ex-Div | 01-Jun-23 | n/a |
Paid | 14-Jun-23 | n/a |
Amount | 1.80p | 0.000¢ |
Time | Volume / Share Price |
16:29 | 910 @ 18.00p |
16:09 | 5,483 @ 18.24p |
15:56 | 26 @ 18.00p |
15:42 | 189 @ 18.00p |
15:08 | 187 @ 18.00p |
CEO | Andrew James Webb |
You are here: research